AsiaMedic Income Statement

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	32.37	28.91	23.6	18.88	18.26	15.28
Other Revenue	0.12	0.17	0.15	0.16	0.17	0.1
Revenue	32.49	29.09	23.75	19.04	18.42	15.38
Revenue Growth (YoY)	24.08%	22.46%	24.72%	3.38%	19.81%	-19.31%
Cost of Revenue	25.05	23.28	18.4	14.78	14.25	12.88
Gross Profit	7.44	5.8	5.35	4.27	4.17	2.49
Selling, General & Admin	0.71	0.12	0.11	0.14	0.14	0.16
Other Operating Expenses	3.12	2.56	2.45	2.15	1.97	1.81
Operating Expenses	7.12	5.16	4.63	3.34	3.38	4.64
Operating Income	0.32	0.65	0.72	0.92	0.79	-2.14
Interest Expense	-0.8	-0.59	-0.42	-0.24	-0.15	-0.2
Interest & Investment Income	0.16	0.17	0.17	0.04	0.02	0.05
Earnings From Equity Investments	0.35	0.32	0.44	0.48	0.36	0.37
Other Non Operating Income (Expenses)	0.02	0.02	-	-	0.09	-0
EBT Excluding Unusual Items	0.06	0.57	0.91	1.21	1.12	-1.92
Impairment of Goodwill	-0.05	-0.05	-	-0.52	-	-
Asset Writedown	0.12	0.12	0.12	1.5	-0.86	-4.19
Other Unusual Items	-	-	-	-	0.45	1.82
Pretax Income	0.13	0.64	1.03	2.19	0.72	-4.3
Income Tax Expense	-0	-0	-0.89	-	-	-
Earnings From Continuing Operations	0.13	0.65	1.92	2.19	0.72	-4.3
Minority Interest in Earnings	0.94	0.36	-	-	-	-
Net Income	1.08	1.01	1.92	2.19	0.72	-4.3
Net Income to Common	1.08	1.01	1.92	2.19	0.72	-4.3
Net Income Growth	-9.26%	-47.44%	-12.13%	205.72%	-	-
Shares Outstanding (Basic)	1,142	1,155	1,132	1,120	1,120	1,094
Shares Outstanding (Diluted)	1,142	1,155	1,132	1,120	1,120	1,094
Shares Change (YoY)	-0.67%	1.97%	1.13%	-	2.36%	178.90%
EPS (Basic)	0.00	0.00	0.00	0.00	0.00	-0.00
EPS (Diluted)	0.00	0.00	0.00	0.00	0.00	-0.00
EPS Growth	-8.74%	-48.76%	-13.11%	225.88%	-	-
Free Cash Flow	0.92	0.68	0.98	0.23	3.06	1.98
Free Cash Flow Per Share	0.00	0.00	0.00	-	0.00	0.00
Gross Margin	22.91%	19.95%	22.52%	22.40%	22.65%	16.23%
Operating Margin	0.99%	2.22%	3.03%	4.85%	4.31%	-13.95%
Profit Margin	3.31%	3.47%	8.09%	11.48%	3.88%	-27.93%
Free Cash Flow Margin	2.84%	2.32%	4.14%	1.23%	16.60%	12.89%
EBITDA	1.08	1.34	1.6	1.19	1.17	-0.94
EBITDA Margin	3.31%	4.59%	6.74%	6.24%	6.35%	-6.14%
D&A For EBITDA	0.75	0.69	0.88	0.27	0.38	1.2
EBIT	0.32	0.65	0.72	0.92	0.79	-2.14
EBIT Margin	0.99%	2.22%	3.03%	4.85%	4.31%	-13.95%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.